On Wednesday, the U.S. Food and Drug Administration (FDA) granted approval for IMAAVY™ (nipocalimab-aahu), Johnson & ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...

Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, ...

Tomatoes produced by Williams Farms Repack LLC have been recalled due to potential contamination of the harmful bacteria.

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

A decision is expected in the fourth quarter of 2025.

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The White House wants to reduce U.S. health spending by more than a quarter next year, with the National Institutes of Health ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...